Details for Patent: 6,863,891
Summary for Patent: 6,863,891
| Title: | Oligopeptide lyophilisate, their preparation and use |
| Abstract: | A novel lyophilizate and method of preparation as well as the use of the lyophilizate to treat female infertility and for gonad protection. Cetrorelix is dissolved in acetic acid 30% v/v, the solution is transferred to water and freeze dried. |
| Inventor(s): | Jürgen Engel, Burkhard Wichert, Dieter Sauerbier, Thomas Reissmann |
| Assignee: | BLITZ F02-570 GmbH , Zentaris IVF GmbH |
| Application Number: | US10/040,457 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 6,863,891
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 6,863,891
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 43 05 225 | Feb 19, 1993 |
International Family Members for US Patent 6,863,891
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 193653 | ⤷ Start Trial | |||
| Australia | 5523594 | ⤷ Start Trial | |||
| Australia | 671881 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
